<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Birkbeck_Conclusion skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Birkbeck/Conclusion</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="cssmenu"><UL><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/Team"><SPAN>Team</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/TeamMembers"><SPAN>Members</SPAN></A></LI><LI class="last"><A href="https://2015.igem.org/Team:Birkbeck/Attributions"><SPAN>Attributions</SPAN></A></LI></UL><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/Research"><SPAN>Research</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Description"><SPAN>Overview</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/pp"><SPAN>Background</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Experiments"><SPAN>Experiments</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Measurement"><SPAN>Measurements</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Modeling"><SPAN>Modelling</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Results"><SPAN>Results</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Conclusion"><SPAN>Conclusion</SPAN></A></LI><LI class="last"><A href="https://2015.igem.org/Team:Birkbeck/Safety"><SPAN>Safety</SPAN></A></LI><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/BioBricks"><SPAN>BioBricks</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Basic_Parts"><SPAN>Basic Parts</SPAN></A></LI><LI class="last"><A href="https://2015.igem.org/Team:Birkbeck/Composite_Part"><SPAN>Composite Parts</SPAN></A></LI><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/Outreach"><SPAN>Outreach</SPAN></A></LI><LI><A href="https://2015.igem.org/Team:Birkbeck/Practices"><SPAN>Human Practices</SPAN></A></LI><LI class="last"><A href="https://2015.igem.org/Team:Birkbeck/Collaborations"><SPAN>Collaborations</SPAN></A></LI><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/InterLab Study"><SPAN>InterLab</SPAN></A></LI><LI class="has-sub"><A href="https://2015.igem.org/Team:Birkbeck/Notebook"><SPAN>Journal</SPAN></A></LI></DIV><DIV id="maincontainer"><H2>Conclusion</H2><H3><B><U>Signal Detection</U></B></H3><P>As mentioned in the discussion of our <A href="https://2015.igem.org/Team:Birkbeck/Measurement">InterLab results</A>, there has been success in the transduction of <I>Mycobacterium</I> cells using mycobacteriophages. These protocols require growing up cells, exposing cells to bacteriophages &amp; conducting a plaque assay. The preliminary results from our study show that fluorescence can be detected from as early as 20-60 minutes of <I>E. coli</I> growth. This would greatly reduce the time frame of pathogen detection. The results of the InterLab study also show that the protocol is adaptable to accommodate different laboratory environments.</P><H3><B><U>BioBricks For Mutagenesis</U></B></H3><P>The short tail fibre (<I>stf</I>) gene was successfully reconstructed with <I>ORF-401</I>&amp;<I>ORF-314</I>. No mutagenesis work was carried out on <I>stf</I>. However, the BioBrick is now available for mutagenesis work &amp; future testing for changes in binding specificity.</P><P>The tail fibre assembly (tfa) protein acts as a molecular chaperone to stf. The cloning of <I>tfa</I> will permit future mutagenesis work, which may facilitate the assembly of mutant <I>stf</I> if problems arise when these mutations are introduced. <I>tfa</I> was only cloned into a circuit &amp; not made into a standalone BioBrick, after which this construct was cloned into a circuit where it is repressed by TetR. The addition of anhydrous tetracycline will alleviate the repression and therefore allow optimisation of <I>tfa</I> expression to give the controlled production of recombinant virions.</P><H3><B><U>BioBricks for the Lytic/Lysogenic Cycle Control</U></B></H3><P>For the biosynthesis of bacteriophage virions for our product, it is essential that the lytic &amp; lysogenic cycles are tightly regulated in order to maximise the number of virions produced. The <I>cI</I>&amp;<I>Cro</I> genes were successfully constructed into a circuit. With <I>cI</I> being constitutively expressed, lysogeny can be maintained for bacterial load to be increased in order to maximise the number of bacteriophage virions to be produced. Meanwhile, the production of <I>T7 RNAP</I> is controlled under a pBAD (araC-regulated) promoter which in turn stimulates the expression of <I>Cro</I>. This control can allow optimisation of when to stimulate the switch from lysogeny to lytic cycle to maximise viral titre in the lysate.</P><P>To find an overview of safety aspects of our project</P><P>Back to main Research page</P></DIV></DIV></DIV></DIV></DIV></BODY></HTML>